SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-031883
Filing Date
2019-08-14
Accepted
2019-08-13 18:42:52
Documents
67
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q stro-10q_20190630.htm 10-Q 2552807
2 EX-31.1 stro-ex311_8.htm EX-31.1 16151
3 EX-31.2 stro-ex312_6.htm EX-31.2 16240
4 EX-32.1 stro-ex321_9.htm EX-32.1 6613
5 EX-32.2 stro-ex322_7.htm EX-32.2 6643
  Complete submission text file 0001564590-19-031883.txt   8562609

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stro-20190630.xml EX-101.INS 1839921
7 XBRL TAXONOMY EXTENSION SCHEMA stro-20190630.xsd EX-101.SCH 62497
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stro-20190630_cal.xml EX-101.CAL 38242
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stro-20190630_def.xml EX-101.DEF 265656
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20190630_lab.xml EX-101.LAB 470259
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20190630_pre.xml EX-101.PRE 391377
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 191022264
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences